Insulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progression (Q34263370)

25276284

1 August 2017

title

Insulin resistance and steatosis in HBV-HCV co-infected patients: Role of PNPLA3 polymorphisms and impact on liver fibrosis progression (English)

1 reference

1 August 2017

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25276284%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25276284%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25276284%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Emanuele Durante-Mangoni

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25276284%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25276284%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25276284%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Aldo Marrone

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25276284%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Luciano Restivo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25276284%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Luigi Elio Adinolfi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25276284%20AND%20SRC:MED&resulttype=core&format=json

Emanuele Miraglia Del Giudice

4 June 2020

object named as

Emanuele Miraglia Del Giudice

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25276284%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Grazia Cirillo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25276284%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Adriana Boemio

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25276284%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Carmine Minichini

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25276284%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Mario Starace

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25276284%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Giovanna Salzillo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25276284%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

Maria Chiara Fascione

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25276284%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

publication date

1 September 2014

1 reference

25276284

World Journal of Hepatology

1 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25276284%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25276284%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25276284%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

page(s)

677-684

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25276284%20AND%20SRC:MED&resulttype=core&format=json

Role of interleukin 28-B in the spontaneous and treatment-related clearance of HCV infection in patients with chronic HBV/HCV dual infection

4 June 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179147

Liver microRNA hsa-miR-125a-5p in HBV chronic infection: correlation with HBV replication and disease progression

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179147

Abdominal fat interacts with PNPLA3 I148M, but not with the APOC3 variant in the pathogenesis of liver steatosis in chronic hepatitis C.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179147

Chronic hepatitis C infection is associated with insulin resistance and lipid profiles

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179147

Hepatitis C virus, cholesterol and lipoproteins--impact for the viral life cycle and pathogenesis of liver disease

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179147

Clinical and virological characteristics of chronic hepatitis B patients with hepatic steatosis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179147

The predictive value of steatosis in hepatitis C virus infection

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179147

The interaction of metabolic factors with HCV infection: does it matter?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179147

Metabolic alterations and chronic hepatitis C: treatment strategies

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179147

Hepatic steatosis in hepatitis B virus infected patients: meta-analysis of risk factors and comparison with hepatitis C infected patients.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179147

Hepatic steatosis and hepatitis C: Still unhappy bedfellows?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179147

Hepatitis C virus hijacks host lipid metabolism

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179147

Hepatitis B and C virus coinfection: a novel model system reveals the absence of direct viral interference

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179147

Hepatitis C and steatosis: a reappraisal

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179147

Steatosis: co-factor in other liver diseases.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179147

Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179147

Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179147

Virological profiles in patients with chronic hepatitis C and overt or occult HBV infection

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179147

Histological grading and staging of chronic hepatitis

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179147

Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection

28 July 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I9.677

High liver RBP4 protein content is associated with histological features in patients with genotype 1 chronic hepatitis C and with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I9.677

Steatosis in chronic hepatitis B: prevalence and correlation with biochemical, histologic, viral, and metabolic parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I9.677

Patatin-like phospholipase domain-containing 3 I148M affects liver steatosis in patients with chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I9.677

HBV superinfection in HCV chronic carriers: a disease that is frequently severe but associated with the eradication of HCV.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I9.677

Tolerability and efficacy of anti-HBV nucleos(t)ide analogues in HBV-DNA-positive cirrhotic patients with HBV/HCV dual infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I9.677

Insulin resistance (HOMA-IR) cut-off values and the metabolic syndrome in a general adult population: effect of gender and age: EPIRCE cross-sectional study.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I9.677

The association of PNPLA3 variants with liver enzymes in childhood obesity is driven by the interaction with abdominal fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I9.677

Treatment of the hepatitis B virus and hepatitis C virus co-infection: still a challenge for the hepatologist

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I9.677

Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I9.677

Insulin resistance and response to telaprevir plus peginterferon α and ribavirin in treatment-naive patients infected with HCV genotype 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I9.677

Current Concepts of HBV/HCV Coinfection: Coexistence, but Not Necessarily in Harmony

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179147

Virological pattern in plasma, peripheral blood mononuclear cells and liver tissue and clinical outcome in chronic hepatitis B and C virus coinfection

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179147

Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179147

Longitudinal evaluation reveals a complex spectrum of virological profiles in hepatitis B virus/hepatitis C virus-coinfected patients

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179147

Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179147

Influence of chronic coinfection with hepatitis B and C virus on liver histology.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179147

Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected].

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179147

Suppression of hepatitis B virus enhancer 1 and 2 by hepatitis C virus core protein

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179147

Mechanisms for inhibition of hepatitis B virus gene expression and replication by hepatitis C virus core protein.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179147

HBV superinfection in hepatitis C virus chronic carriers, viral interaction, and clinical course.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179147

Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179147

Characteristics of patients with dual infection by hepatitis B and C viruses

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179147

A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179147

The relative roles of hepatitis B and C viruses in the etiology of hepatocellular carcinoma in southern African blacks

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4179147

Distinct, alcohol-modulated effects of PNPLA3 genotype on progression of chronic hepatitis C

28 October 2018

1 reference

https://api.crossref.org/works/10.4254%2FWJH.V6.I9.677

Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography

21 January 2018

1 reference

12 December 2020

Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C

1 reference

12 December 2020

The APOC3 T-455C and C-482T promoter region polymorphisms are not associated with the severity of liver damage independently of PNPLA3 I148M genotype in patients with nonalcoholic fatty liver

1 reference

12 December 2020

EASL Clinical Practice Guidelines: management of hepatitis C virus infection

1 reference

12 December 2020

Impact of patatin-like phospholipase-3 (rs738409 C>G) polymorphism on fibrosis progression and steatosis in chronic hepatitis C

1 reference

12 December 2020

Patatin-Like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C

1 reference

12 December 2020

Identifiers

DOI

10.4254/WJH.V6.I9.677

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25276284%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25276284%20AND%20SRC:MED&resulttype=core&format=json

4 June 2020

25276284

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25276284%20AND%20SRC:MED&resulttype=core&format=json